NCT00696137View on ClinicalTrials.gov

Long-term Extension Study of BEMA™ Fentanyl

PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Respiratory Depression
Interventions
DRUG

BEMA Fentanyl

buccal soluble film; 200, 400, 600, 800, and 1200 mcg fentanyl; up to 4 times daily

Sponsors
All Listed Sponsors
lead

BioDelivery Sciences International

INDUSTRY